Hyperfine Swoop vs Qure.ai
Qure.ai reads X-rays and head CTs while Hyperfine builds a brain scanner, so no purchase puts them head to head. Qure.ai sells to hospitals and TB screening programs. Its qER head CT triage was cleared in 2020 (K200921), qXR-LN covers lung nodules on adult frontal chest radiographs, and Qure.ai reports a WHO endorsement from 2021 for TB screening. An independent 12-product evaluation put qXR v3 at 95.5% sensitivity and 48.7% specificity at one threshold. Hyperfine sells to ICUs and resource-limited hospitals. A Malawi case review praises Swoop for bedside brain imaging where a fixed MRI suite is out of reach, and a research paper estimates about $50,000 per system. Qure.ai publishes no price, and Hyperfine's 10-K summary describes ownership plus an annual service agreement.
Radiology · Reviewed November 2, 2026
Hyperfine Swoop
by Hyperfine
Portable 0.064T brain MRI (Swoop) with Optive AI image reconstruction. Also BrainInsight AI brain morphometry.
Qure.ai
by Qure.ai
AI for chest X-ray (qXR), head CT (qER) and lung nodule CT, with TB screening. The homepage cites sites across 107 countries.
When to pick each one
Hyperfine Swoop
- Malawi review praises bedside brain imaging
- Older research paper estimates about $50,000 per system
Qure.ai
- qER head CT triage, 510(k) cleared in 2020
- Qure.ai reports a WHO endorsement for TB screening, 2021
- CE Class IIb under MDR for qXR v4.0 and qCT
Score
Each row shows points earned of points available under the published rubric.
Hyperfine Swoop
47of 100
Qure.ai
50of 100
| Dimension | Hyperfine Swoop | Qure.ai | Difference |
|---|---|---|---|
| FDA clearance | 18 / 18 | 18 / 18 | 0 |
| HIPAA / SOC2 / BAA | 0 / 10 | 0 / 10 | 0 |
| EHR integrations (count) | 0 / 4.2 | 0 / 4.2 | 0 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 2.4 | 0 / 2.4 | 0 |
| Peer-reviewed papers | 12.7 / 18.2 | 12.7 / 18.2 | 0 |
| RCT / meta-analysis / systematic review | 0 / 7.8 | 0 / 7.8 | 0 |
| Funding & adoption signal | 6 / 12 | 8.4 / 12 | -2.4 |
| Pricing transparency | 2.5 / 5 | 2.5 / 5 | 0 |
| Years in market | 0 / 6 | 0 / 6 | 0 |
Scroll horizontally to see every column.
Pricing
Hyperfine Swoop
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. Per the FY2025 10-K summary, systems are owned, with an annual software, service and support agreement after a one-year warranty on 36- or 60-month terms. Dollar amounts were not found. |
Qure.ai
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. Grant funding is not stated on Qure pages. |
Evidence
Hyperfine Swoop
FDA decisions
K262622 (opens in new tab)510(k)2026-08-19
Swoop
K253489 (opens in new tab)510(k)2025-12-12
Swoop
K250236 (opens in new tab)510(k)2025-05-30
Swoop (V2)
K251276 (opens in new tab)510(k)2025-05-21
Swoop
K240944 (opens in new tab)510(k)2024-07-16
Swoop
Show 12 more
K232760 (opens in new tab)510(k)2023-10-06
Swoop
K230208 (opens in new tab)510(k)2023-02-22
Swoop
K223268 (opens in new tab)510(k)2022-12-16
BrainInsight
K223247 (opens in new tab)510(k)2022-12-06
Swoop
K221923 (opens in new tab)510(k)2022-07-28
Swoop
K220815 (opens in new tab)510(k)2022-07-19
BrainInsight
K221393 (opens in new tab)510(k)2022-06-10
Swoop
K212456 (opens in new tab)510(k)2021-11-17
Swoop
K211818 (opens in new tab)510(k)2021-07-07
Swoop
K202414 (opens in new tab)510(k)2021-01-07
BrainInsight
K201722 (opens in new tab)510(k)2020-08-11
Hyperfine POC MRI
K192002 (opens in new tab)510(k)2020-02-06
Lucy POC MRI
Peer-reviewed
4 PubMed records name Hyperfine Swoop.
- Super resolution using sparse sampling at portable ultra-low field MR. (opens in new tab)
- Tips and challenges for clinical use and interpretation of low field portable MRI in neuroimaging. (opens in new tab)
- Case-based review of low-field MRI in resource-constrained settings: a clinical perspective from Malawi. (opens in new tab)
Qure.ai
FDA decisions
K261517 (opens in new tab)510(k)2026-09-14
qCT Lung v1.0
K251934 (opens in new tab)510(k)2026-01-16
qXR-Detect
K251610 (opens in new tab)510(k)2025-09-08
qER-CTA v1.0
K240740 (opens in new tab)510(k)2024-08-16
qCT LN Quant
K231805 (opens in new tab)510(k)2023-12-22
qXR-LN
Show 5 more
K231149 (opens in new tab)510(k)2023-09-22
qXR-CTR
K230899 (opens in new tab)510(k)2023-08-22
qXR-PTX-PE
K212690 (opens in new tab)510(k)2021-12-21
qXR-BT
K211222 (opens in new tab)510(k)2021-07-30
qER-Quant
K200921 (opens in new tab)510(k)2020-06-17
qER
Peer-reviewed
4 PubMed records name Qure.ai.
- Radiograph accelerated detection and identification of cancer in the lung (RADICAL): a mixed methods study to assess the clinical effectiveness and acceptability of Qure.ai artificial intelligence software to prioritise chest X-ray (CXR) interpretation. (opens in new tab)
- Revolutionizing Healthcare: Qure.AI's Innovations in Medical Diagnosis and Treatment. (opens in new tab)
- A Case Series From a Multicentric Study: Can Artificial Intelligence (AI)-Enabled Chest X-Ray Assist in the Incidental Detection of Early-Stage Lung Cancers? (opens in new tab)
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Hyperfine Swoop | Qure.ai |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Not specified |
| Founded | n/a | n/a |
| HQ | US | IN |
Scroll horizontally to see both columns.
Common questions
Open the full radiology comparison
Acute-care triage, mammography screening, CCTA plaque analysis, mobile MRI. 30+ FDA-cleared platforms across stroke, oncology, cardiac. Enterprise sales only — we compared what's deployed where.